Editorial medical review pending. This educational content has not yet received documented physician sign-off. The clinical claims and references are subject to physician verification.
Quick answer: Vaginal PRP, also described as platelet-rich plasma for female sexual dysfunction, has been studied as an investigational treatment for selected female sexual-function and pelvic-floor concerns, including reduced arousal or sensation, orgasm difficulty, vaginal dryness, dyspareunia, and stress urinary incontinence. Early studies are small and heterogeneous, so PRP should not be presented as a proven or FDA-approved treatment for these conditions.
Book a consultation · What to expect at a PRP visit
What Is Vaginal PRP?
Vaginal PRP is a descriptive term for platelet-rich plasma prepared from a patient’s own blood and injected into selected vulvovaginal, periurethral, clitoral, or related tissues depending on the clinical concern and protocol. The term is sometimes used when discussing platelet-rich plasma for female sexual dysfunction, but there is no single standardized procedure. Injection sites, platelet preparation, number of sessions, and outcome measures differ among published studies and clinical protocols.
Platelet-Rich Plasma for Female Sexual Dysfunction
Female sexual dysfunction is an umbrella term that can include problems with desire, arousal, lubrication, orgasm, satisfaction, or pain. PRP has been investigated for some of these concerns, but female sexual symptoms are multifactorial and should not automatically be attributed to tissue changes that an injection can correct. Menopause, estrogen deficiency, medications, pelvic-floor disorders, neurologic conditions, pain syndromes, childbirth-related changes, psychological factors, and relationship factors may all contribute.
Why women seek evaluation
- Reduced genital sensation or arousal
- Difficulty reaching orgasm
- Vaginal dryness
- Pain with intercourse
- Menopausal or postpartum sexual changes
- Stress urinary leakage
What does the research show?
A systematic review of studies involving female sexual dysfunction and stress urinary incontinence found improvements in some patient-reported outcomes, but the authors emphasized that the evidence level was low because of small studies, heterogeneous protocols, and methodological limitations. Better randomized trials are needed.
Female sexual symptoms deserve a diagnosis
Sexual symptoms can arise from menopause and estrogen deficiency, pelvic-floor dysfunction, medications, pain disorders, relationship or psychological factors, endocrine conditions, neurologic disease, childbirth injury, and other causes. Treatment should address the underlying problem rather than assuming PRP is appropriate.
What benefits have actually been studied?
Small clinical studies have examined platelet-rich plasma injections for female sexual-function symptoms and some urinary concerns. Researchers have measured arousal, lubrication, orgasm, satisfaction, pain, and sexual distress using questionnaires such as the Female Sexual Function Index. Other studies have measured stress urinary leakage. Some participants reported improvement after treatment, but these reports are not proof that PRP caused the improvement or that a similar result can be expected for an individual patient.
A 2023 systematic review included 12 studies involving 327 women across female sexual dysfunction and stress urinary incontinence. Most studies were observational, treatment protocols varied, and the authors judged the overall evidence to be low quality. The review did not establish a standard treatment schedule or demonstrate reliable long-term efficacy. Research findings should therefore be discussed as preliminary, not as established benefits.
What vaginal PRP cannot currently promise
- Reliable improvement in arousal or ability to reach orgasm
- Permanent restoration of genital sensation or nerve function
- A proven cure for pain with intercourse or menopausal vaginal dryness
- Predictable reduction in stress urinary leakage
- A standardized number of injections or lasting result
Outcomes may vary because sexual function depends on hormonal health, pelvic-floor function, nervous-system signaling, medications, pain, psychological well-being, and relationship context. A procedure directed at one tissue cannot be assumed to correct every contributor.
What happens before considering an investigational injection?
An evaluation should clarify the patient’s principal concern and its duration, onset, severity, and effect on quality of life. Clinicians may review menopausal or postpartum changes, current medications (including antidepressants), pelvic pain, recurrent infections, diabetes, prior surgery, neurologic symptoms, and urinary leakage. A focused examination or testing may be appropriate when indicated. Patients should be able to describe their treatment goals and understand which outcomes are measurable.
For new genital numbness, significant pelvic pain, bleeding, unusual discharge, recurrent urinary symptoms, or other concerning changes, the priority is appropriate medical assessment rather than an elective PRP procedure. A pelvic-floor specialist, gynecologist, urologist, or sexual-medicine clinician may be useful depending on the findings.
Established options worth discussing first
When symptoms relate to genitourinary syndrome of menopause, nonprescription vaginal lubricants and moisturizers can help mild symptoms. For more persistent or moderate-to-severe symptoms, evidence-based options may include low-dose vaginal estrogen, vaginal DHEA, or ospemifene, selected according to individual history, risks, and preferences. The 2020 Menopause Society position statement reviews these approaches. Pelvic-floor physical therapy can be useful for muscle dysfunction or pain. Medication adjustment, treatment of a contributing medical condition, and psychosexual counseling may be appropriate for some arousal or orgasm concerns.
Stress urinary incontinence warrants a distinct evaluation; pelvic-floor muscle training, pessary management, and selected procedural or surgical approaches have established roles. PRP is not a substitute for these options. Treatment choices should follow the diagnosis, not a generic promise of rejuvenation.
Safety, consent, and follow-up
PRP is prepared from the patient’s blood, but that does not make injections risk-free. Possible complications include injection-site pain, bruising, bleeding, infection, and tissue or nerve injury. Available studies are too small to rule out uncommon complications or establish long-term safety for genital injections. There is no universally accepted preparation, injection-site, or dosing protocol for female sexual-function indications.
Before considering PRP, ask what evidence applies to the specific symptom, what alternatives are available, what the complete cost includes, what adverse events are possible, and how outcomes would be assessed. Symptom questionnaires, pain scores, and follow-up conversations can be more informative than promotional before-and-after photographs. No improvement should be guaranteed.
Clinical and regulatory disclosure: PRP injections for female sexual dysfunction, menopausal vaginal symptoms, and stress urinary incontinence remain investigational uses; they are not FDA-approved treatments for these indications. This page is educational, and its clinical content awaits documented physician review.
Supporting Articles for Vaginal PRP & Female Sexual Dysfunction
This is the primary landing page for vaginal PRP and platelet-rich plasma for female sexual dysfunction. The guides below support this page by addressing narrower symptom, cost, results, menopause, and evidence questions.
Explore educational guides to vaginal PRP results and before-and-after expectations, vaginal PRP cost in Los Angeles and Beverly Hills, vaginal PRP for menopause, PRP for female arousal and orgasm, PRP and vaginal dryness, PRP and stress urinary incontinence, and PRP for painful intercourse.
Clinical principle: Female sexual-health symptoms deserve an individualized assessment of hormonal, pelvic-floor, neurologic, medication-related, vascular, pain-related, and psychosocial contributors before considering an investigational procedure.
Important: PRP for sexual-function concerns is investigational/off-label. Evidence is limited and heterogeneous, and PRP should not be presented as a proven cure or replacement for established evaluation and treatment.
